Suppr超能文献

烷基和2-苯乙基1,4-二氢-2,6-二甲基-3-硝基-4-(3-或6-取代-2-吡啶基)-5-吡啶羧酸酯的合成、旋转异构体取向及钙通道调节活性

Synthesis, rotamer orientation, and calcium channel modulation activities of alkyl and 2-phenethyl 1,4-dihydro-2,6-dimethyl-3-nitro-4-(3- or 6-substituted-2-pyridyl)-5-pyridinecarboxylates.

作者信息

Iqbal N, Akula M R, Vo D, Matowe W C, McEwen C A, Wolowyk M W, Knaus E E

机构信息

Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, Alberta, Canada T6G 2N8.

出版信息

J Med Chem. 1998 May 21;41(11):1827-37. doi: 10.1021/jm970529f.

Abstract

A group of racemic alkyl and 2-phenethyl 1,4-dihydro-2,6-dimethyl-3-nitro-4-(3- or 6-substituted-2-pyridyl)-5-pyridinecarboxylates (13a-q) was prepared using a modified Hantzsch reaction that involved the condensation of a 3- or 6-substituted-2-pyridinecarboxaldehyde (7a-j) with an alkyl or 2-phenethyl 3-aminocrotonate (11a-d) and nitroacetone (12). Nuclear Overhauser (NOE) studies indicated there is a significant rotamer fraction in solution where the pyridyl nitrogen is oriented above the 1,4-dihydropyridine ring, irrespective of whether a substituent is located at the 3- or 6-position. A potential H-bonding interaction between the pyridyl nitrogen free electron pair and the suitably positioned 1,4-dihydropyridine NH moiety may stablize this rotamer orientation. In vitro calcium channel antagonist and agonist activities were determined using guinea pig ileum longitudinal smooth muscle (GPILSM) and guinea pig left atrium (GPLA) assays, respectively. Compounds having an i-Pr ester substituent acted as dual cardioselective calcium channel agonists (GPLA)/smooth muscle-selective calcium channel antagonists (GPILSM), except for the C-4 3-nitro-2-pyridyl compound which exhibited an antagonist effect on both GPLA and GPILSM. In contrast, the compounds with a phenethyl ester group, which exhibited antagonist activity (IC50 = 10(-5)-10(-7) M range) on GPILSM, were devoid of cardiac agonist activity on GPLA. Structure-activity relationships showing the effect of a substituent (Me, CF3, Cl, NO2, Ph) at the 3- or 6-position of a C-4 2-pyridyl moiety and a variety of ester substituents (Me, Et, i-Pr, PhCH2CH2-) upon calcium channel modulation are described. Compounds possessing a 3- or 6-substituted-2-pyridyl moiety, in conjuction with an i-Pr ester substituent, are novel 1,4-dihydropyridine calcium channel modulators that offer a new drug design approach directed to the treatment of congestive heart failure and may also be useful as probes to study the structure-function relationships of calcium channels.

摘要

使用改良的汉茨希反应制备了一组外消旋烷基和2-苯乙基1,4-二氢-2,6-二甲基-3-硝基-4-(3-或6-取代-2-吡啶基)-5-吡啶羧酸酯(13a-q),该反应涉及3-或6-取代-2-吡啶甲醛(7a-j)与烷基或2-苯乙基3-氨基巴豆酸酯(11a-d)和硝基丙酮(12)的缩合反应。核Overhauser(NOE)研究表明,无论取代基位于3-位还是6-位,溶液中都存在相当一部分旋转异构体,其中吡啶基氮位于1,4-二氢吡啶环上方。吡啶基氮自由电子对与适当定位1,4-二氢吡啶NH部分之间潜在的氢键相互作用可能使这种旋转异构体取向稳定。分别使用豚鼠回肠纵行平滑肌(GPILSM)和豚鼠左心房(GPLA)试验测定体外钙通道拮抗剂和激动剂活性。具有异丙酯取代基的化合物作为双心脏选择性钙通道激动剂(GPLA)/平滑肌选择性钙通道拮抗剂(GPILSM)起作用,但C-4 3-硝基-2-吡啶基化合物对GPLA和GPILSM均表现出拮抗作用。相比之下,具有苯乙酯基团的化合物在GPILSM上表现出拮抗活性(IC50 = 10(-5)-10(-7) M范围),在GPLA上没有心脏激动剂活性。描述了结构-活性关系,显示了C-4 2-吡啶基部分3-或6-位上的取代基(Me、CF3、Cl、NO2、Ph)和各种酯取代基(Me、Et、i-Pr、PhCH2CH2-)对钙通道调节的影响。具有3-或6-取代-2-吡啶基部分并与异丙酯取代基结合的化合物是新型1,4-二氢吡啶钙通道调节剂,为充血性心力衰竭的治疗提供了一种新的药物设计方法,也可能用作研究钙通道结构-功能关系的探针。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验